• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白 B:脂质学的罗塞塔石碑。

Apolipoprotein B: the Rosetta Stone of lipidology.

机构信息

Department of Medicine, Sunnybrook Health Sciences Centre, Division of Nephrology, Toronto, Ontario.

Department of Medicine, Mike and Valeria Rosenbloom Centre for Cardiovascular Prevention, McGill University Health Centre, Montreal, Quebec, Canada.

出版信息

Curr Opin Endocrinol Diabetes Obes. 2021 Apr 1;28(2):90-96. doi: 10.1097/MED.0000000000000596.

DOI:10.1097/MED.0000000000000596
PMID:33229928
Abstract

PURPOSE OF REVIEW

This review summarizes the evidence that apolipoprotein B (apoB) integrates the conventional lipid markers - total cholesterol, triglycerides, LDL-cholesterol, and non-HDL-cholesterol - into a single index that accurately and simply quantitates the atherogenic risk due to the apoB lipoprotein particles.

RECENT FINDINGS

Marked hypertriglyceridemia remains the essential signal for hyperchylomicronemia and potential pancreatitis. However, with the exception of Lp(a) and the abnormal cholesterol-enriched remnant particles that are the hallmark of type III hyperlipoproteinemia, recent evidence from discordance analyses and Mendelian randomization indicate that apoB integrates the risk due to the atherogenic lipoprotein particles because all LDL particles are, within the limits of our ability to measure any differences, equally atherogenic and all, except the largest VLDL particles are, within the limits of our ability to measure any differences, equally atherogenic.

SUMMARY

Measuring apoB as well as the conventional lipids is essential for accurate diagnosis. For almost all follow-up, however, apoB is all that need be measured. ApoB is the Rosetta Stone of lipidology because dyslipoproteinemia cannot be understood unless apoB is measured.

摘要

目的综述

本综述总结了载脂蛋白 B(apoB)将传统脂质标志物——总胆固醇、甘油三酯、LDL-胆固醇和非 HDL-胆固醇——整合为一个单一指数的证据,该指数能够准确、简单地定量由于 apoB 脂蛋白颗粒导致的动脉粥样硬化风险。

最近的发现

明显的高甘油三酯血症仍然是高乳糜微粒血症和潜在胰腺炎的重要信号。然而,除了 Lp(a)和作为 III 型高脂蛋白血症特征的异常富含胆固醇的残粒外,来自不一致性分析和孟德尔随机化的新证据表明,apoB 整合了由于动脉粥样硬化脂蛋白颗粒导致的风险,因为所有 LDL 颗粒在我们能够测量任何差异的范围内,都是同等的动脉粥样硬化,而且除了最大的 VLDL 颗粒外,在我们能够测量任何差异的范围内,都是同等的动脉粥样硬化。

总结

测量 apoB 以及传统脂质对于准确诊断至关重要。然而,对于几乎所有的随访,apoB 是唯一需要测量的。apoB 是脂质学的罗塞塔石碑,因为如果不测量 apoB,就无法理解脂蛋白异常。

相似文献

1
Apolipoprotein B: the Rosetta Stone of lipidology.载脂蛋白 B:脂质学的罗塞塔石碑。
Curr Opin Endocrinol Diabetes Obes. 2021 Apr 1;28(2):90-96. doi: 10.1097/MED.0000000000000596.
2
The spectrum of type III hyperlipoproteinemia.III 型高脂蛋白血症谱。
J Clin Lipidol. 2018 Nov-Dec;12(6):1383-1389. doi: 10.1016/j.jacl.2018.09.006. Epub 2018 Sep 14.
3
Effects of evolocumab in individuals with type 2 diabetes with and without atherogenic dyslipidemia: An analysis from BANTING and BERSON.依洛尤单抗对伴或不伴致动脉粥样硬化性血脂异常的 2 型糖尿病患者的影响:来自 BANTING 和 BERSON 的分析。
Cardiovasc Diabetol. 2021 Apr 30;20(1):94. doi: 10.1186/s12933-021-01287-6.
4
Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review.载脂蛋白 B 颗粒与心血管疾病:一篇叙述性综述。
JAMA Cardiol. 2019 Dec 1;4(12):1287-1295. doi: 10.1001/jamacardio.2019.3780.
5
Non-HDL Cholesterol or apoB: Which to Prefer as a Target for the Prevention of Atherosclerotic Cardiovascular Disease?非高密度脂蛋白胆固醇还是载脂蛋白 B:预防动脉粥样硬化性心血管疾病,哪个指标更适合作为靶点?
Curr Cardiol Rep. 2020 Jun 19;22(8):67. doi: 10.1007/s11886-020-01323-z.
6
Physiological Bases for the Superiority of Apolipoprotein B Over Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk.载脂蛋白 B 优于低密度脂蛋白胆固醇和非高密度脂蛋白胆固醇作为心血管风险标志物的生理基础。
J Am Heart Assoc. 2022 Oct 18;11(20):e025858. doi: 10.1161/JAHA.122.025858. Epub 2022 Oct 10.
7
Phenotypes of hypertriglyceridemia caused by excess very-low-density lipoprotein.由过多极低密度脂蛋白引起的高甘油三酯血症的表型。
J Clin Lipidol. 2012 Sep-Oct;6(5):427-33. doi: 10.1016/j.jacl.2012.04.081. Epub 2012 May 1.
8
Identification and partial characterization of discrete apolipoprotein B containing lipoprotein particles produced by human hepatoma cell line HepG2.人肝癌细胞系HepG2产生的含离散载脂蛋白B脂蛋白颗粒的鉴定及部分特性分析
Biochemistry. 1987 Jul 28;26(15):4837-46. doi: 10.1021/bi00389a035.
9
A More Atherogenic Lipoprotein Status Is Present in Adults With Type 2 Diabetes Mellitus Than in Those Without With Equivalent Degrees of Hypertriglyceridemia.与具有同等程度的高三酰甘油血症的非 2 型糖尿病患者相比,2 型糖尿病患者具有更易致动脉粥样硬化的脂蛋白状态。
Can J Diabetes. 2022 Jul;46(5):480-486. doi: 10.1016/j.jcjd.2022.02.001. Epub 2022 Feb 9.
10
Quantifying the contribution of lipoprotein(a) to all apoB containing particles.定量脂蛋白(a)对所有载 apoB 颗粒的贡献。
J Clin Lipidol. 2022 Mar-Apr;16(2):220-226. doi: 10.1016/j.jacl.2022.02.004. Epub 2022 Feb 12.

引用本文的文献

1
ApoB/ApoA-Ι is associated with major cardiovascular events and readmission risk of patients after percutaneous coronary intervention in one year.载脂蛋白B/载脂蛋白A-Ι与主要心血管事件及经皮冠状动脉介入治疗术后患者一年内的再入院风险相关。
Sci Rep. 2025 Jan 6;15(1):996. doi: 10.1038/s41598-024-84092-x.
2
Blood lipid metabolic biomarkers are emerging as significant prognostic indicators for survival in cancer patients.血脂代谢生物标志物正逐渐成为癌症患者生存的重要预后指标。
BMC Cancer. 2024 Dec 18;24(1):1549. doi: 10.1186/s12885-024-13265-8.
3
Establishing Apolipoprotein-B and non-high-density-lipoprotein-C goals in Indian population: A Cross-sectional study.
在印度人群中设定载脂蛋白 B 和非高密度脂蛋白 C 目标:一项横断面研究。
Indian Heart J. 2024 May-Jun;76(3):154-158. doi: 10.1016/j.ihj.2024.06.003. Epub 2024 Jun 12.
4
Tracking of apolipoprotein B levels measured in childhood and adolescence: systematic review and meta-analysis.儿童期和青少年期载脂蛋白B水平的追踪:系统评价与荟萃分析。
Eur J Pediatr. 2024 Feb;183(2):569-580. doi: 10.1007/s00431-023-05350-0. Epub 2023 Dec 5.
5
Apolipoprotein B is associated with CT-angiographic progression beyond low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in patients with coronary artery disease.载脂蛋白 B 与冠状动脉疾病患者的 CT 血管造影进展相关,超出了低密度脂蛋白胆固醇和非高密度脂蛋白胆固醇的范围。
Lipids Health Dis. 2023 Aug 9;22(1):125. doi: 10.1186/s12944-023-01872-6.
6
[Not Available].[无可用内容]。
Can Fam Physician. 2022 Sep;68(9):e256-e263. doi: 10.46747/cfp.6809e256.
7
Approach to risk stratification of atherosclerotic cardiovascular disease: Use of biomarkers and imaging in a Canadian context.动脉粥样硬化性心血管疾病风险分层方法:加拿大语境下的生物标志物和影像学的应用。
Can Fam Physician. 2022 Sep;68(9):654-660. doi: 10.46747/cfp.6809654.
8
Efficacy and Mechanism of Roxadustat plus Oral Iron in the Treatment of Elderly Chronic Kidney Disease with Anemia.罗沙司他联合口服铁剂治疗老年慢性肾脏病伴贫血的疗效及机制
Evid Based Complement Alternat Med. 2022 Jun 25;2022:9192655. doi: 10.1155/2022/9192655. eCollection 2022.
9
Effect of Berberine on Cardiovascular Disease Risk Factors: A Mechanistic Randomized Controlled Trial.小檗碱对心血管疾病危险因素的影响:一种基于机制的随机对照试验。
Nutrients. 2021 Jul 26;13(8):2550. doi: 10.3390/nu13082550.
10
Triglyceride-rich lipoprotein and LDL particle subfractions and their association with incident type 2 diabetes: the PREVEND study.富含甘油三酯的脂蛋白和 LDL 颗粒亚组份及其与 2 型糖尿病发病的关系:PREVEND 研究。
Cardiovasc Diabetol. 2021 Jul 28;20(1):156. doi: 10.1186/s12933-021-01348-w.